Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rebecca Park


Associate Professor and Honorary Consultant Psychiatrist

  • Head of OxBread Research Group
  • Associate Professor in Eating Disorders Psychiatry
  • Hon Consultant Psychiatrist : Oxford Health NHS Foundation Trust & Oxford University Hospitals NHS Foundation Trust.
  • Visiting Professor, Department of Brain Sciences, Imperial College London

Senior Clinical Researcher - Translational studies in Eating Disorders

Research themes:

My translational research focuses on defining the neural, psychological and somatic processes underpinning eating disorders , and using this deeper understanding to derive and develop new forms of treatment.The transdisciplinary work of my team 'OxBread' and wider collaborators allows us to think' outside the box' to develop novel treatment strategies.

In particular I investigate  the most severe form of eating disorder,  Anorexia Nervosa, because more effective  forms of treatment are urgently  needed: Anorexia Nervosa has the highest mortality of any psychiatric disorder , at huge costs  to individual lives and  health care services. Anorexia Nervosa often leads to chronic morbidity, and current treatment strategies are limited. It is thus essential to develop novel, more effective treatments based on an understanding of the key processes maintaining the illness.

Since 2010 In collaboration with neuroscientists and neurosurgeons at the University of Oxford ,  we have investigated aberrant  neural processes underlying  Anorexia Nervosa  and from this are  developing new forms of treatment targeting these processes, such as Brain Stimulation . Since 2020 I have also been  collaborating with Professor David Nutt and  team at the Centre for Psychedelic studies,  Imperial College London in a study of psilocybin as a treatment for Anorexia Nervosa.  Our  investigations use cutting edge forms of brain imaging in addition to psychological experiments. The ethics of treatment research is central to my work and I  particularly value the voice of patients  in guiding our studies- and  use their accounts to guide the development of exciting new approaches to treatment .  We strive to reduce stigma, promote recovery and reduce the cost on individuals  their families and health services.

Extensive clinical experience with patients is central to my research:  I was the first Consultant psychiatrist- to  Oxfords inpatient unit at Cotswold house from 2003 and then worked in the NHS eating disorders service for 15 years before deciding to focus exclusively  on clinical research studies since 2018.   I have been particularly involved with supporting  students with eating disorders.

Additionally, I teach and examine undergraduates and postgraduates in preclinical and clinical medicine about eating disorders, and supervise  PhD students.